The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Novavax, Inc(NASDAQ:NVAX) 
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one...
Website: http://www.novavax.com
Founded: 1987
Full Time Employees: 522
CEO: Stanley C. Erck
Sector: Healthcare
Industry: Biotechnology
Novavax Number of Twitter Followers
Novavax Days Payable Outstanding ttm (DPO)
Novavax Days Receivable Outstanding ttm (DSO)
Novavax Days Inventory Outstanding ttm (DIO)
Novavax Op Cashflow Per Share ttm
Novavax Free Cashflow Per Share ttm
Novavax Cash Per Share ttm
Novavax P/S ratio ttm
Novavax (GAAP) P/E ratio ttm
Novavax P/B ratio ttm
No extra charts and metrics for this ticker.